NCT04181970 Observational Study, for Quality Assessment, of Sarcoma in European and Latin American Multidisciplinary NETWORK
| NCT ID | NCT04181970 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Grupo Espanol de Investigacion en Sarcomas |
| Condition | Soft-tissue Sarcoma |
| Study Type | OBSERVATIONAL |
| Enrollment | 5,000 participants |
| Start Date | 2019-06-30 |
| Primary Completion | 2026-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 5,000 participants in total. It began in 2019-06-30 with a primary completion date of 2026-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Post-authorisation, multicentric, observational, retrospective and prospective study to assess quality of care of sarcoma patients in expert and non-expert centers by analysing correlation of quality items and outcomes such as relapse free survival, overall survival, percentage of amputation, etc. Expert pathology peer review will be performed to detect differences between expert and non-expert centers as well as differences in treatment and patient prognosis. Tumor samples of 4 types of sarcoma would also be included in translational research to detect biomarkers and produce preclinical models.
Eligibility Criteria
Inclusion Criteria: * Histological diagnosis of soft-tissue sarcoma, GIST or bone sarcoma (all subtypes) from January 2005 until Juny/September 2023. * ≥ 18 years * Available clinical and treatment information Exclusion Criteria: There is no exclusion criteria
Contact & Investigator
Javier MARTIN-BROTO, MD
PRINCIPAL INVESTIGATOR
Salud de Madrid
Frequently Asked Questions
Who can join the NCT04181970 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 120 Years, studying Soft-tissue Sarcoma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04181970 currently recruiting?
Yes, NCT04181970 is actively recruiting participants. Contact the research team at martamartinruiz@atbsarc.org for enrollment information.
Where is the NCT04181970 trial being conducted?
This trial is being conducted at Buenos Aires, Argentina, São Paulo, Brazil, Heredia, Costa Rica, Lyon, France and 5 additional locations.
Who is sponsoring the NCT04181970 clinical trial?
NCT04181970 is sponsored by Grupo Espanol de Investigacion en Sarcomas. The principal investigator is Javier MARTIN-BROTO, MD at Salud de Madrid. The trial plans to enroll 5,000 participants.